144 related articles for article (PubMed ID: 14565238)
61. Synthesis, anti-HIV activity studies, and in silico rationalization of cyclobutane-fused nucleosides.
Figueras A; Miralles-Llumà R; Flores R; Rustullet A; Busqué F; Figueredo M; Font J; Alibés R; Maréchal JD
ChemMedChem; 2012 Jun; 7(6):1044-56. PubMed ID: 22504900
[TBL] [Abstract][Full Text] [Related]
62. An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
Chamorro C; Camarasa MJ; Pérez-Pérez MJ; de Clercq E; Balzarini J; San Félix A
Antivir Chem Chemother; 1998 Sep; 9(5):413-22. PubMed ID: 9875394
[TBL] [Abstract][Full Text] [Related]
63. Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues.
El-Sayed WA; El-Essawy FA; Ali OM; Nasr BS; Abdalla MM; Abdel-Rahman AA
Z Naturforsch C J Biosci; 2009; 64(11-12):773-8. PubMed ID: 20158144
[TBL] [Abstract][Full Text] [Related]
64. KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis.
Harris KS; Brabant W; Styrchak S; Gall A; Daifuku R
Antiviral Res; 2005 Jul; 67(1):1-9. PubMed ID: 15890415
[TBL] [Abstract][Full Text] [Related]
65. Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.
Zaccarelli M; Perno CF; Forbici F; Cingolani A; Liuzzi G; Bertoli A; Trotta MP; Bellocchi MC; Di Giambenedetto S; Tozzi V; Gori C; D'Arrigo R; De Longis P; Noto P; Girardi E; De Luca A; Antinori A
Antivir Ther; 2003 Feb; 8(1):51-6. PubMed ID: 12713064
[TBL] [Abstract][Full Text] [Related]
66. Synthesis of 4'-C-ethynyl and 4'-C-cyano purine nucleosides from natural nucleosides and their anti-HIV activity.
Kohgo S; Yamada K; Kitano K; Sakata S; Hayakawa H; Nameki D; Kodama E; Matsuoka M; Mitsuya H; Ohrui H
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):887-9. PubMed ID: 14565303
[TBL] [Abstract][Full Text] [Related]
67. Understanding the mode of action of L-nucleosides as antiviral agents: a molecular modeling approach.
Lee K; Chong Y; Chu CK
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):385-8. PubMed ID: 11563052
[TBL] [Abstract][Full Text] [Related]
68. Simple synthesis and anti-HIV activity of novel cyclopentene phosphonate nucleosides.
Kim A; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):1-8. PubMed ID: 16440980
[TBL] [Abstract][Full Text] [Related]
69. Synthesis of a nucleoside bioconjugate system as a potential anti-HIV agent.
Van Calenbergh S; Nair V
Nucleosides Nucleotides; 1999; 18(4-5):737-8. PubMed ID: 10432675
[TBL] [Abstract][Full Text] [Related]
70. Synthesis and antiviral evaluation of the beta-L-enantiomers of some thymine 3'-deoxypentofuranonucleoside derivatives.
Mathé C; Gosselin G
Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1517-30. PubMed ID: 11200256
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and evaluation of novel 6',6'-difluoro 5'-deoxycarbocyclic phosphonic acid nucleosides as antiviral agents.
Kim E; Shen GH; Kang L; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2013; 32(7):396-410. PubMed ID: 23742064
[TBL] [Abstract][Full Text] [Related]
72. Truncated reverse isoxazolidinyl nucleosides: a new class of allosteric HIV-1 reverse transcriptase inhibitors.
Romeo R; Giofrè SV; Macchi B; Balestrieri E; Mastino A; Merino P; Carnovale C; Romeo G; Chiacchio U
ChemMedChem; 2012 Apr; 7(4):565-9. PubMed ID: 22323191
[No Abstract] [Full Text] [Related]
73. Synthesis and evaluation of 2'-substituted cyclobutyl nucleosides and nucleotides as potential anti-HIV agents.
Li Y; Mao S; Hager MW; Becnel KD; Schinazi RF; Liotta DC
Bioorg Med Chem Lett; 2007 Jun; 17(12):3398-401. PubMed ID: 17434736
[TBL] [Abstract][Full Text] [Related]
74. Potential of 4'-C-substituted nucleosides for the treatment of HIV-1.
Hayakawa H; Kohgo S; Kitano K; Ashida N; Kodama E; Mitsuya H; Ohrui H
Antivir Chem Chemother; 2004 Jul; 15(4):169-87. PubMed ID: 15457679
[TBL] [Abstract][Full Text] [Related]
75. New acyclonucleosides: synthesis and anti-HIV activity.
Hadj-Bouazza A; Zerrouki R; Krausz P; Laumond G; Aubertin AM; Champavier Y
Nucleosides Nucleotides Nucleic Acids; 2005; 24(8):1249-63. PubMed ID: 16270666
[TBL] [Abstract][Full Text] [Related]
76. Synthesis of novel acyclic nucleoside analogues with anti-retroviral activity.
Paju A; Päri M; Selyutina A; Zusinaite E; Merits A; Pehk T; Siirde K; Müürisepp AM; Kailas T; Lopp M
Nucleosides Nucleotides Nucleic Acids; 2010 Sep; 29(9):707-20. PubMed ID: 20706961
[TBL] [Abstract][Full Text] [Related]
77. Synthesis and biological activity of modified thiopyrimidine nucleosides.
Attia AM; Sallam MA; Almehdi AA; Abbasi MM
Nucleosides Nucleotides; 1999 Oct; 18(10):2307-15. PubMed ID: 10616732
[TBL] [Abstract][Full Text] [Related]
78. Deoxythreosyl phosphonate nucleosides as selective anti-HIV agents.
Wu T; Froeyen M; Kempeneers V; Pannecouque C; Wang J; Busson R; De Clercq E; Herdewijn P
J Am Chem Soc; 2005 Apr; 127(14):5056-65. PubMed ID: 15810840
[TBL] [Abstract][Full Text] [Related]
79. Design, synthesis, antiviral activity, and pre-formulation development of poly-L-arginine-fatty acyl derivatives of nucleoside reverse transcriptase inhibitors.
Pemmaraju BP; Malekar S; Agarwal HK; Tiwari RK; Oh D; Doncel GF; Worthen DR; Parang K
Nucleosides Nucleotides Nucleic Acids; 2015; 34(1):1-15. PubMed ID: 25513860
[TBL] [Abstract][Full Text] [Related]
80. Synthesis of 3'-halo-5'-norcarbocyclic nucleoside phosphonates as potent anti-HIV agents.
Hamon N; Kaci M; Uttaro JP; Périgaud C; Mathé C
Eur J Med Chem; 2018 Apr; 150():642-654. PubMed ID: 29558735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
